Tigers ace Tarik Skubal gave the team a scare last week when he exited his start due to tightness in his left side. The obvious initial concern was that Skubal had suffered an oblique or intercostal strain that could necessitate a notable absence, but subsequent testing did not reveal a major injury. Several days of rest appear to have eased any discomfort the Cy Young front-runner was feeling. Skubal told the Tigers beat yesterday that he felt “100 percent” one day after bullpen session.
“If anything, I probably worked a little bit harder just to make sure that I was good to go,” Skubal said of Monday’s bullpen session (via Evan Woodbery of MLive.com). “There was nothing there. It was all good.”
Skubal added that he fully anticipates making his next start tomorrow. He called last week’s early exit “one of those weird things” and wasn’t sure what had caused the discomfort, but for now, it seems the issue is largely behind him. For a Tigers club that’s already lost Reese Olson and Jackson Jobe for the season, Skubal’s ostensibly clean bill of health creates an even greater sigh of relief.
Outside of Skubal, Detroit’s rotation has been a mess since the trade deadline. Neither Charlie Morton nor Chris Paddack, the Tigers’ two rotation additions ahead of the deadline, has bolstered the staff. Morton sports a woeful 5.92 ERA in eight starts since coming to the Motor City, and Paddack has already been moved to the bullpen after posting a 6.38 ERA in five starts. Jack Flaherty (5.14 ERA in his past eight starts) and Casey Mize (4.85 ERA in his past eight starts) have also been limping to the finish line. Overall, the Tigers’ rotation has a 4.77 ERA dating back to Aug. 1 — and that number skyrockets to 5.40 when subtracting Skubal’s contributions.
The Tigers deployed their “pitching chaos” tactic to great effect late last season, using Skubal as their lone traditional starter and otherwise deploying an all-hands-on-deck approach. They haven’t reverted to that form just yet, and it’s worth noting that both Mize and Flaherty have had some strong starts in the past couple weeks. Presumably, Flaherty and Mize are the favorites for postseason starts behind Skubal right now, but last year’s approach showed that the Tigers aren’t beholden to conventional setups with their pitching staff.
Detroit is also hoping for some reinforcements in the bullpen sooner than later. Yesterday’s injury report from the club indicated that right-hander Kyle Finnegan tossed a bullpen session yesterday. He landed on the shelf earlier this month due to an adductor strain. Evan Petzold of the Detroit Free Press tweets that Finnegan, who tossed 14 1/3 shutout innings after being acquired from the Nationals in July, could embark on a rehab assignment in the near future.
Fellow deadline pickup Paul Sewald has already started his own rehab assignment as he works back from a July shoulder injury. He’s allowed one run and punched out four hitters in 4 2/3 innings of rehab work — most recently pitching two-thirds of an inning just last night. A return shouldn’t be too far off, barring any late setbacks.
While the updates on Skubal, Finnegan and Sewald are largely positive, the news regarding outfielder/third baseman Matt Vierling is far less rosy. Vierling, out since early August due to an oblique strain, began a minor league rehab assignment earlier this week. However, the Tigers announced in their latest injury report that Vierling has been pulled from that rehab stint after just one game due to continued soreness in his oblique region.
“I’m going to stop short of calling it a setback because I don’t know that yet,” manager AJ Hinch said last night (via Chris McCosky of the Detroit News). “But it’s clearly slowed down our plan with him. He’s pretty bummed out about it and he should be. We are, too. It’s just a matter of being re-evaluated and seeing what he can tolerate and what we can hope for.”
Hinch didn’t declare Vierling out for the season but conceded that the best he could answer regarding Vierling’s playoff availability was a simple, “I don’t know.” Presumably, Detroit will have more information on his status in the next few days.
It’s been a frustrating season for Vierling, who turned 29 the same day he had to be pulled from that rehab stint. He’s been limited to just 31 games and 100 plate appearances due to a pair of shoulder injuries and a pair of strains in his left oblique. When on the active roster, he’s turned in a tepid .239/.310/.307 batting line.
That pedestrian line is a far cry from Vierling’s quietly solid .257/.312/.423 performance during a 2024 season that saw him connect on a career-high 16 home runs. Vierling also set highwater marks in doubles (28), games played (144) and plate appearances (567). On the other side of the ball, he chipped in passable glovework at third base and above-average defense across all three outfield spots. It’s still possible he makes it back to the roster, particularly if the Tigers go on a deep run in October, but a return doesn’t appear to be on the immediate horizon.
